Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)*
|
ENVERIC BIOSCIENCES, INC. (Name of Issuer) |
Common Stock, $0.01 par value per share (Title of Class of Securities) |
29405E505 (CUSIP Number) |
12/09/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 29405E505 |
| 1 | Names of Reporting Persons
Northstrive Fund II LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person: Mr. Lichti is, as of the date of this Amendment No. 1 to Schedule 13G ("Amendment No. 1"), the Manager of Northstrive Fund II LP. As of December 9, 2025, (please refer to Item 4 of this Amendment No. 1, below, for additional detail in relation to this date), the Reporting Person(s) are no longer beneficial owners or no longer deemed to be beneficial owners of any shares of Common Stock of Enveric Biosciences, Inc., a Delaware corporation (the "Issuer").
SCHEDULE 13G
|
| CUSIP No. | 29405E505 |
| 1 | Names of Reporting Persons
Braeden Lichti | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: Mr. Lichti is, as of the date of this Amendment No. 1, the Manager of Northstrive Fund II LP. As of December 9, 2025, (please refer to Item 4 of this Amendment No. 1, below, for additional detail in relation to this date), the Reporting Person(s) are no longer beneficial owners or no longer deemed to be beneficial owners of any shares of Common Stock of the Issuer.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
ENVERIC BIOSCIENCES, INC. | |
| (b) | Address of issuer's principal executive offices:
245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142 | |
| Item 2. | ||
| (a) | Name of person filing:
This statement is filed by: (i) Northstrive Fund II LP, a Delaware limited partnership; and (ii) Braeden Lichti ("Mr. Lichti"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." | |
| (b) | Address or principal business office or, if none, residence:
120 Newport Center Drive, Suite 250 Newport Beach, CA 92660 | |
| (c) | Citizenship:
Northstrive Fund II LP is a Delaware corporation. Mr. Lichti is a citizen of Canada. | |
| (d) | Title of class of securities:
Common Stock, $0.01 par value per share | |
| (e) | CUSIP No.:
29405E505 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
Pursuant to Rule 13d-2 promulgated under the Securities Exchange Act of 1934, as amended, this Amendment No. 1 to Schedule 13G/A (this "Amendment No. 1") amends and supplements the Schedule 13G originally filed with the U.S. Securities and Exchange Commission on December 5, 2025 (the "Original Schedule 13G"). This Amendment No. 1 relates to the Common Stock of the Issuer, owned by the Reporting Persons and is the final amendment to the Original Schedule 13G and an exit filing for the Reporting Persons. | |
| (b) | Percent of class:
Northstrive Fund II LP: 0% Braeden Lichti: 0% %
| |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
Northstrive Fund II LP: 0 Braeden Lichti: 0 | ||
| (ii) Shared power to vote or to direct the vote:
Northstrive Fund II LP: 0 Braeden Lichti: 0 | ||
| (iii) Sole power to dispose or to direct the disposition of:
Northstrive Fund II LP: 0 Braeden Lichti: 0 | ||
| (iv) Shared power to dispose or to direct the disposition of:
Northstrive Fund II LP: 0 Braeden Lichti: 0 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|